Breaking News

ACRO Appoints Global Regulatory VP

By Kristin Brooks | March 20, 2014

Noonan to build relationships with regulators and alliance partners

Karen A. Noonan has been appointed vice president of Global Regulatory Policy at the Association of Clinical Research Organizations (ACRO). Ms. Noonan most recently served as senior advisor for health policy at Onyx Pharmaceuticals. Prior to that she was director of State Government Affairs and Grassroots Advocacy at the American Society of Health System Pharmacists (ASHP).
 
“We welcome Karen to the ACRO team and are confident she will continue to build our relationships with regulators and alliance partners in the United States, Europe and around the globe,” said ACRO executive director Doug Peddicord, Ph.D. “We see a tremendous opportunity for CROs to take a more pro-active position in regulatory policy as our members play an increasingly important role in medical product development.”
 
Additionally, John Lewis will serve as senior vice president, policy and public affairs. Mr. Lewis previously served as vice president of Public Affairs with the association.
blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision